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Abstract 
 
Discouraging bacterial colonization of ocular biomaterials and implants is a significant challenge in 
ophthalmology as infections often lead to the need for secondary surgery, with associated risks and 
additional stress to patients. In this work we demonstrate for the first time the feasibility of an 
innovative antibacterial ocular prosthesis produced by depositing a silver nanocluster/silica 
composite layer on the poly(methyl methacrylate) implant surface via radio-frequency sputtering. 
Tape test performed according to relevant ASTM standard provided a preliminary evidence of the 
mechanical stability and good adhesion of the coating to the substrate (absence of macroscopic 
damage after tape removal). Coating integrity was maintained after prolonged soaking in aqueous 
medium (1 month). The antibacterial effect of the coating, associated to silver ion release upon 
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contact with aqueous fluid, was confirmed by the in vitro formation of a 5-mm inhibition halo test 
against Staphylococcus aureus that is one of the most common bacteria involved in ocular 
infections. The approach proposed in the present study for facing implant-related ocular infections 
can have a significant impact in the field of ophthalmic biomaterials, suggesting a valuable 
alternative to the administration of antibiotics that may become ineffective due to bacterial 
resistance.  
 
Keywords: Ophthalmic biomaterial; Coating; Silver; Sputtering; Antibacterial.  
 
1. Introduction 
 
Bacterial issues in ophthalmic applications, with particular reference to postoperative infection of 
ocular implants, cause significant problems that can require additional, stressful and expensive 
treatments for the patients [1-6]. In this regard, bacterial infections have dramatic consequences for 
those patients who underwent enucleation procedures, which involve the removal of the ocular 
globe due to tumours, oculo-orbital trauma or otherwise untreatable diseases followed by 
implantation of an artificial eye [7]. In these cases, an orbital implant is inserted in the anophthalmic 
socket with the aim of filling the orbital volume, allowing normal circulation of tears and 
supporting the eyelids (Fig. 1a). An aesthetic ocular prosthesis is usually worn by the patient to 
mimic the features of the normal contralateral eye (Fig. 1b and c). 
The most commonly-used orbital implants are designed as porous spheres made of hydroxyapatite, 
polyethylene or alumina that, once implanted in the patient’s ocular socket, are invaded by 
fibrovascular tissue [8,9]. Poly(methyl methacrylate) (PMMA) is used to produce both serial and 
custom-made ocular prostheses that are placed between the closed conjunctival surface covering the 
orbital implant and the eyelid [10]. Usually, the acrylic resin is cast into a properly-designed mould 
reproducing the exterior features of the patient’s eye and the scleral curvature; then, after 
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polymerization, the final PMMA ocular prosthesis is carefully hand-painted to achieve the best 
aesthetic effect, i.e. the perfect similarity with the healthy contralateral eye (Fig. 1b). 
Over the years, some strategies have been experimented to limit the risk of bacterial colonization at 
the time of surgery; for instance, it is a common practice to impregnate porous hydroxyapatite 
orbital implants in antibiotics prior to implantation in the orbital socket [11]. This approach is 
certainly useful intraoperatively, but a key challenge of modern ophthalmology is to develop smart 
biomaterials able to exert a long-term antibacterial effect in order to prevent late infections. 
Moreover, the widespread and increasing use of antibiotics led to the development of antibiotic-
resistant bacterial strains, which have been recently indicated as a “global threat” [12]; therefore, 
there is the need for investigating alternative strategies to treat bacterial infections. 
In the literature, there is a relative paucity of publications reporting the development of “smart” 
ocular devices with antiseptic properties. In a recent patent, Jun et al. [13] disclosed an antibacterial 
ocular prosthesis produced by incorporating small amounts of silver, gold or platinum nanoparticles 
in acrylic resin or silicone used to fabricate the prosthesis. Following a similar approach, Yang et al. 
[14] produced a PMMA-based ocular prosthesis by dispersing silver nanoparticles in acrylic resin 
(concentration between 300 and 700 ppm) and tested its antibacterial properties in vitro against 
Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli. 
The antimicrobial activity of this Ag-containing artificial eye was significantly stronger than that of 
as-such polymeric controls. Both approaches, however, pose a serious problems associated to the 
possible release of nano-sized silver, which could be a crucial issue for the real implant applicability 
in the clinical practice since many studies have demonstrated the cell/tissue toxicity of metal 
nanoparticles in vitro and in vivo [15,16]. 
Exploiting metal ion release from biomaterial surfaces for antibacterial purposes has been shown to 
be a valuable and promising strategy, not only in the field of ophthalmology [17]. As to the specific 
application considered in the present work, it cannot be ignored that the ocular environment is a 
particularly complex one and several parameters should be taken into account when designing 
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suitable implants and devices; for instance, the interaction of Ag+ ions with the tears, the fate of the 
ions released and the possible ion-induced conjunctival tissue necrosis are all aspects deserving 
careful consideration in future research. As such a topic is very new, the relevant available literature 
is quite scarce; Hau and Tuft [18] recently described a case of corneal argyrosis associated with 
silver nitrate-coated cosmetic soft contact lenses that a 67-year-old woman wore for 17 years for the 
management of intractable diplopia: this is a typical example of an apparently unexpected side 
effect detectable only after many years of follow-up. 
A promising strategy that has been recently proposed in a patent by Baino et al. [19] involves the 
deposition of an antibacterial silver nanocluster/silica composite coating on the surface of ocular 
prostheses by radio-frequency (RF) co-sputtering of silver and silica used as target materials. This 
strategy is expected to overcome the drawbacks of the antibacterial device proposed by Yang et al. 
[14], including the toxicity of the released nanosilver and the high cost of the metal nanoparticles to 
be incorporated in the bulk of the prosthesis. Our approach is founded on the use of RF sputtering, 
that is recognized as a versatile technique adopted to obtain coatings with different features and 
intended for a wide range of applications [20,21]; among them, the ability to deposit antibacterial 
layers on various surfaces for healthcare, clinical or, in general, everyday use has received 
increasing attention in the last years [22-26]. For the first time, this work reports the feasibility and 
characterisation of silver nanocluster/silica composite antibacterial coatings deposited on the rear 
surface of PMMA ocular prostheses to be used in contact with the patient’s conjunctiva (Fig. 1a). 
This approach is novel and, to the best of the authors’ knowledge, has never been applied in the 
field of ocular biomaterials.  
 
2. Materials and methods 
 
2.1. Preparation of the samples 
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Silver nanocluster/silica composite coatings were deposited by RF co-sputtering of silica and silver 
(targets) onto PMMA substrates. For the purpose of simplicity, the feasibility of these antibacterial 
coatings was first explored in a simplified, flat geometry; then, the same processing schedule was 
applied to real PMMA ocular prostheses (Fig. 1b,c). Before being sputtered, all the samples were 
cleaned with ethanol; the PMMA ocular prostheses (Zabby’s Ophthalmic Instruments and Devices, 
India) were also cut in four quadrants by means of an automatic cutting machine (Accutom 5, 
Struers) using a diamond blade (330 CA, Struers). The depositions were performed for 15 or 40 
minutes (coated samples will be hereafter referred to as C15 and C40, respectively) with a plasma 
power of 200 W RF on the silica target (purity 99.9%, Franco Corradi Srl) and 1 W DC on the 
silver target (purity 99.99%, Sigma-Aldrich). In order to better tailor the amount of silver in the 
coating, the plasma over the silver target was periodically switched OFF and ON with a duty cycle 
of 6 – 2 seconds (Ag plasma ON for 2 seconds over a 6-second period). Coating depositions were 
all performed in pure argon atmosphere. 
 
2.2. Characterisation studies 
 
Morphological and compositional investigations of the coatings were carried out by field-emission 
scanning electron microscopy (FESEM, SUPRATM 40, Zeiss) equipped with X-ray energy 
dispersive spectroscopy (EDS); the samples were chromium-coated before the analysis. 
The adhesion of the coating to PMMA flat substrate was evaluated by tape test (Fig. 2) according to 
the ASTM D 3359 standard [27]. The aim of this test is to measure (semi-quantitatively) the 
strength of a film deposited on a substrate; specifically, it is possible to define the resistance 
category of the coating by analysing the macro-damages of the film. 
Silver release from the coatings was estimated by soaking sputtered quadrants of PMMA ocular 
prostheses in double-distilled water used as a testing medium. Specifically, four samples (quadrants 
of prosthesis) per type (C15 and C40) were immersed in double-distilled water contained in 
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polyethylene flasks (25 ml for each sample, static conditions) at 37 °C up to 1 month. The amount 
of silver released in the solution was measured at different time points, namely 3 h, 1, 2, 7, 14 and 
28 days. At each time point the samples were extracted from the solution and immersed in 25 ml of 
fresh one. The solution was analyzed in order to determine the silver content by means of a specific 
spectrophotometer (HI 93737, Hanna Instruments) after the addition of proper reagents (HI93737-
03 Kit Silver reagents 150 TEST). The reaction between silver (in the solution) and the reagents 
causes an orange coloration that can be used to determine the concentration of silver by the 
spectrophotometer. The method is an adaptation of the 1-(2-pyridylazo)-2-naphthol (PAN) 
technique [28]. Data were expressed as mean ± SD (calculated on four measurements) of the silver 
released per unit area of the ocular prosthesis (coated with the silver/silica layer and exposed to the 
testing solution). Results were analyzed by Student’s t-test; statistical significance was set at p < 
0.05.  
EDS analyses were also performed in order to determine the silver and silicon amount in the coating 
before immersion and after the whole soaking period (1 month). 
Assessment of the antibacterial effect of the coatings was performed by the inhibition halo test, 
according to the protocols of the National Committee for Clinical Laboratory Standards (NCCLS) 
[29] by using Staphylococcus aureus strain (ATCC 29213). Staphylococcus aureus was selected as 
it is one of the most important and common human bacterial pathogens involved in ocular 
infections [30]. Briefly, a 0.5 McFarland suspension, containing approximately 1.5×108 colony 
forming units (CFU)/ml was prepared and uniformly spread on Mueller Hinton agar plate; the 
samples were placed in contact with the agar and incubated overnight at 37 °C. After incubation for 
24 h, the inhibition halo was observed and measured. Test was performed in triplicate; pure (non-
coated) PMMA was used as a control. 
 
3. Results and discussion 
 
 7 
A typical PMMA ocular prosthesis used in this work is shown in Fig. 1b and c; Fig. 1d displays the 
morphology of the polymeric surface to be coated. Quadrants of the PMMA ocular prostheses that 
underwent coating deposition are shown in Fig. 3; from a qualitative viewpoint, it is possible to 
observe that a higher deposition time (40 min vs. 15 min) is associated to a darker colour of the 
sputtered surface due to the higher silver content in the coating.   
The surfaces of the coatings were investigated by FESEM and revealed an irregular, cauliflower-
like morphology typical of sputtered silica with silver nanoclusters visible as bright “dots” (Fig. 4a). 
Average size of silver nanoclusters was around 10 nm, as roughly estimated by the high-
magnification micrograph reported in Fig. 4b. The EDS analysis (Table 1) revealed Ag/Si atomic 
ratios of 0.29 and 0.45 for C15 and C40 samples, respectively; these quantitative findings are 
consistent with the qualitative observations reported in Fig. 3. 
The results of the tape test are shown in Fig. 5: the application and subsequent removal of the tape 
from the surface of the coated PMMA flat sample, after the incision of a grid of parallel cuts on the 
surface, induced no alteration of the coating both inside and outside the grid compared to the 
sample before the test. No traces of the coating, which might have been removed partially by the 
tape, were found on the tape surface after the test. Therefore, according to the ASTM D 3359 
standard [27], the sample can be classified as belonging to the 5B class (no damage), which 
demonstrates a good adhesion of the silver nanocluster/silica composite coating to the PMMA 
substrate.  
As to the soaking test in double-distilled water, Fig. 6 shows a progressive discoloration of the 
sample surface during the immersion period. After 28 days, the C15 sample surface is almost white, 
whereas the C40 one still maintains a brownish appearance. 
As demonstrated by the surface investigations (FESEM analyses) reported in Fig. 7, after 28 days of 
immersion in double-distilled water the silver nanocluster/silica composite coatings are still visible 
on the surface of both samples (C15 and C40) and exhibit a morphology unaltered with respect to 
that of as-deposited coatings (Fig 4a). EDS analyses (Table 1) showed that at the end of the testing 
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period (28 days) the Ag/Si atomic ratios decreased to 0.09 and 0.21 for C15 and C40 samples, 
respectively. These results suggest that the coating discoloration illustrated in Fig. 6 is due to 
progressive silver depletion from the coating; in fact, the brown colour of the coating is attributed to 
the presence of silver nanoclusters, whereas the silica matrix is almost colourless. 
The antibacterial activity of silver is related to the progressive release of Ag+ ions into the body 
fluids; then, the amount of silver released from the coating into the testing medium at different 
experimental times was assessed by a specific spectrophotometer for Ag+ ions and the obtained 
results are reported in Fig. 8. The cumulative release was calculated by summing up the silver 
content in the solutions assessed at the different time points; the obtained curves are shown in Fig. 
9. The C15 samples seemed to have completely released the silver contained in the coating at the 
end of the testing period (silver was almost totally depleted after 14 days of soaking in double-
distilled water), whereas the C40 samples were still releasing silver after 1 month; these results are 
consistent with the qualitative observations illustrated in Fig. 6 and the EDS analyses performed on 
the sample surface at the end of the testing period (Table 1). 
Best fitting of the experimental data plotted in Fig. 9 can be performed by using a logarithmic 
interpolating function:   
BtAc += ln
                                                                      (1) 
wherein c (µg cm-2) is the cumulative amount of silver released per unit area of the ocular 
prosthesis, t is the soaking time, A and B are the model constants. 
The interpolating functions and the coefficients of determination R2 for the C15 and C40 samples 
are, respectively, the following: 
46.58ln64.5515 += tcC     (R2 = 0.9416)                                     (2) 
93.29ln09.14140 −= tcC     (R2 = 0.9893)                                     (3) 
Fitting results exhibit good agreements with experimental data, as demonstrated by the high values 
of the coefficients R2, which also reveal the good predictive capability of the presented approach. 
 9 
For the purpose of discussion, it is instructive to compare the results from the leaching test obtained 
in the present work with those reported by other authors and concerning the antibacterial effect of 
silver. Berger et al. [31] reported that the minimum inhibitory concentration (MIC) of Ag+ ions for 
various strains of Staphylococcus aureus is in the 0.03-0.25 µg ml-1 range. Cumulative silver ion 
releases (mean values) at 24 h were around 0.34 and 0.60 µg ml-1 for C15 and C40 samples, 
respectively; therefore, comparison between these data and the reference ones [31] suggests that the 
coated ocular prostheses could exhibit an antibacterial effect. This hypothesis is in full accordance 
with the experimental evidence obtained from the antibacterial test. The antibacterial effect of C15 
samples was demonstrated by the inhibition zone test (Fig. 10): Ag+ ions, deriving from the 
nanoclusters embedded in the composite coating (shown in Fig. 4b) diffused into the culture agar 
and were responsible for the formation of a reproducible and significant inhibition halo of about 5.0 
± 0.5 mm around the samples (Fig. 10a). Fig. 10b shows that this halo can be divided in two zones: 
the bacterial proliferation was totally inhibited near to the sample (1.5 ± 0.5 mm), whereas a limited 
bacterial growth was observed in the peripheral region of the halo (2 to 5 mm from the sample). As 
expected, pure PMMA tested as a control was unable to create an inhibition zone.  
It is instructive to underline that Staphylococcus aureus is a Gram-positive bacterium and it is 
known that Gram-positive bacteria are less susceptible to antibacterial agents than Gram-negative 
strains [32,33]. Therefore, being the silver nanocluster/silica composite coating effective against 
Staphylococcus aureus, it is expected to have an even more significant antibacterial effect towards 
Gram-negative bacterial strains, too. 
A preliminary indication about the potential toxicity of the sputtered surfaces investigated in the 
present work can be provided through a comparison with available data from the literature. The 
cytotoxicity threshold of silver ions (for L929 fibroblasts) has been estimated to be 0.0035 mmol l-1 
[34], which is slightly higher than the average value of cumulative release from C15 samples at 24 h 
(0.003151 mmol l-1). In the case of C40 samples, the threshold value is overcome after 24 h 
(0.005375 mmol l-1), which suggests the risk of cell toxicity. However, the silver release in vitro 
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cannot be directly related to an in vivo behaviour, because of the different boundary conditions 
involving the turnover of biological fluids (tears) in the ocular environment; furthermore, the 
different chemical composition between real physiological fluids (tears) and the model fluid used in 
the present work (double-distilled water) may result in different release kinetics. Therefore, testing 
in double-distilled water gives only an approximate estimate of what may occur in an in vivo 
scenario.  
It cannot be ignored that under physiological conditions, i.e. in the presence of biological fluids 
containing chloride ions and proteins, a rapid conversion of Ag ions to AgCl and Ag-organo-
complexes will occur, which can reduce the biological activity [35,36]. 
As far as the safety of the coating is concerned, it is worth pointing out that silver nanoclusters are 
embedded in the silica matrix in a stable way and only silver ions are released but not nanoparticles, 
as recently observed by Ferraris et al. who investigated the suitability of analogous coatings for 
different substrates and applications [37].  
From the above-reported preliminary results, the silver nanocluster/silica composite coatings 
produced in this work can be considered potentially suitable for the intended application on 
ophthalmic implants, as they elicit a good antibacterial effect against Staphylococcus aureus, one of 
the pathogenic strain most involved in the development of biomaterial-associated infection 
development [38], and exhibit a satisfactory adhesion to the PMMA substrate as well as stability 
upon prolonged soaking in aqueous media. In vitro biocompatibility of silver nanocluster/silica 
composite coatings has been evaluated on other polymeric substrates in a previous work with 
promising results [39].  
 
4. Limitations of the present study and future work 
 
This study is limited by the low sample number in all experiments, which is mainly related to the 
difficult availability and high cost of high-quality ocular prostheses. Therefore, we would like to 
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emphasise that more detailed antibacterial and biological tests with larger sample number are 
required to fully elucidate and prove the antiseptic effect and tissue response of the present silver 
nanoscluster/silica-coated ocular prosthesis. 
Evidence of the antibacterial effect of the coating has been provided by the inhibition halo test; 
additional microbiological tests could be performed in a dedicated study. On the other hand, the 
ability of analogous coatings to reduce bacterial adhesion was already demonstrated in a previous 
work [40].  
The biocompatibility of PMMA is well-recognized from decades and that of analogous silver/silica 
coatings has been recently proven in vitro in a previous work [39]. To the best of the authors’ 
knowledge, no specific biological test is recommended in the literature or is routinely applied to 
assess the biocompatibility of ocular prostheses. This is probably due to the paucity of innovation in 
the field and the common use of highly biocompatible PMMA for such an application. In general, 
advanced biological in vitro tests on ophthalmic biomaterials are relatively scarce in the literature, 
probably due to the difficult availability of appropriate ocular cell types that often derive from 
surgical discard (very delicate primary cells). In this regard, human orbital fibroblasts were 
occasionally used in contact with orbital implant materials [41] and keratocytes were employed to 
characterize the in vitro biocompatibility of artificial corneas [42,43]. As ocular prostheses are 
intended to be in contact with the patient’s conjunctiva, the use of epithelial cells could be 
suggested for detailed in vitro testing in a future work. 
We would like to point out that the cytotoxicity also depends on the amount/releasing profile of 
silver ions. A systematic study focusing on the influence of different silver amount in the coating as 
well as the silver release profiles on cytotoxicity remains to be done.  
Cytotoxicity testing with appropriate cell types is useful to avoid unnecessary, time-consuming and 
expensive animal experiments. However, according to most scientists, there is no recognized 
alternative to pre-clinical animal trials in order to progress the development of biomedical implants 
towards the final stage of clinical trials (human patients). The ideal implantation site for ophthalmic 
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biomaterials is the eye with its unique physiological and microenvironmental characteristics; 
however, this requires the expertise and availability of a skilled ophthalmic surgeon to perform 
operation [44]. In order to simplify the experiments, some authors proposed a rabbit skin 
subcutaneous model to investigate the in vivo biocompatibility of ophthalmic biomaterials for 
artificial cornea [45]; a similar approach could be also followed in the future to test the antibacterial 
biomaterials proposed in the present work. Another important issue is the investigation of the 
systemic/organ toxicity induced by the degradation products (including ions) released by implanted 
biomaterials. A recent, pilot study by Yun et al. [46] – although dealing with a non-ocular 
application – could be considered as a starting point for future work. 
 
5. Conclusions 
 
In this work, antibacterial properties were imparted for the first time to a polymeric ocular 
prosthesis by means of silver nanocluster/silica composite coatings deposited by RF sputtering. The 
antibacterial activity was related to the ability of the coated samples to release silver ions in 
solution, as verified by leaching tests. The coated samples were able to produce a significant 
inhibition halo against Staphylococcus aureus. The coatings were mechanically well-adherent to 
PMMA substrates. The use of metal ions as antibacterial agents instead of antibiotics, which are 
commonly employed in therapy and for the prevention of implant-related infections, could 
overcome the problem of bacterial resistance and could also be effective on resistant bacterial 
strains. 
The results reported in this study are promising and encourage further research, which should 
involve the cross-fertilization among different disciplines. In the next few years, ever increasing 
cooperation between materials scientists, chemists, biologists, ophthalmic surgeons and researchers 
working in the medical implant industry would be more than desirable for the selection and 
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marketing of more suitable and cost-effective biomaterials for managing the anophthalmic socket in 
order to further improve the patient’s quality of life. 
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Figure captions 
 
Fig. 1. Devices for oculoplasty: (a) scheme of application (1 = orbital implant substituting the 
ocular globe removed after enucleation, 2 = patient’s conjunctiva, 3 = ocular prosthesis, 4 = 
antibacterial silver nanosclusters/silica composite coating deposited on the prosthesis surface in 
contact with the conjunctiva; this idea is proposed in this work for the first time); (b) visual 
appearance of a poly(methyl methacrylate) ocular prosthesis (or “scleral shell”) mimicking the 
aesthetics of normal eye; (c) rear region of the ocular prosthesis intended to be put in contact with 
the conjunctiva and to be coated (in the present work) with the antibacterial silver 
nanosclusters/silica composite layer; (d) FESEM micrograph of the rear surface of the prosthesis 
used in this work (magnification 50000×). 
 
Fig. 2. Scheme of tape test procedure on coated samples. 
 
Fig. 3. Visual appearance of the ocular prostheses after the deposition of silver nanosclusters/silica 
composite coatings (deposition time: 15 or 40 minutes) on the rear surface of the PMMA prosthesis. 
 
Fig. 4. Morphological analyses on a coating produced with a deposition time of 15 min (samples 
C15): (a) and (b) FESEM micrographs of the silver nanosclusters/silica composite coating surface 
at different magnifications (figure (b) is in back-scattering mode and the contrast is emphasized in 
order to highlight the presence of silver nanoclusters, that are visible as bright spots). 
Magnifications: (a) 700000×, (b) 900000×.  
 
Fig. 5. Tape test results on a flat silver nanocluster/silica composite coated C15 sample (deposition 
time: 15 min). 
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Fig. 6. Silver nanocluster/silica composite coatings on ocular prostheses: visual appearance after 
different soaking times in double-distilled water (deposition time of the coating: 15 and 40 
minutes). 
 
Fig. 7. Analysis of the surface of the silver nanocluster/silica composite coatings after soaking of 
the ocular prostheses for 28 days in double-distilled water: (a) and (b) C15 sample; (c) and (d) C40 
sample. Magnifications: (a) and (c) 50000×, (b) and (d) 500000×. 
 
Fig. 8. Silver ion release from silver nanocluster/silica composite coated ocular prostheses 
(deposition time of the coatings: 15 and 40 min) after different soaking times in double distilled 
water (p < 0.05 for C15 vs C40 at each time point). 
 
Fig. 9. Cumulative silver release (in double-distilled water) from the silver nanocluster/silica 
composite coated ocular prostheses. The fitting curves (“theo”) are compared to experimental data 
(“exp”). 
 
Fig. 10. Inhibition halo test by using Staphylococcus aureus strain to evaluate the antibacterial 
activity of the silver nanocluster/silica composite coated samples: (a) general view of a C15 sample 
(deposition time of the coating: 15 min) and (b) magnification of the inhibition halo that can be 
divided in two regions: 1 = zone of complete bacterial inhibition, 2 = zone wherein limited bacterial 
growth is allowed. 
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Tables 
 
Table 1. Compositional assessment (at.%) of the coatings (EDS). Analyses were performed on 
three regions of the coating and are expressed as mean ± SD. 
Sample Si Ag 
C15 as such 77.5 ± 2.2 22.5 ± 1.5 
C40 as such 68.9 ± 2.1 31.1 ± 1.7 
C15 after 28 days in double-distilled water 91.7 ± 2.8 8.3 ± 1.5 
C40 after 28 days in double-distilled water 82.6 ± 2.7 17.4 ± 1.2 
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